Professor Sarah Parish
BSc, MSc, DPhil
Professor of Medical Statistics and Epidemiology
- MRC Programme Leader
Sarah Parish studied Mathematics at Bristol and Oxford Universities and joined the unit which became CTSU (and is now part of NDPH) in 1978. She has played a major role as a statistician in the establishment, conduct and interpretation of CTSU’s series of ground-breaking large-scale randomised trials in the treatment and prevention of cardiovascular disease. She has also been active in developing large-scale blood-based observational studies with extensive biomarker panels and genotyping. As the Director of Statistics in Vascular Trials and Genetic Epidemiology, she now leads statistical teams engaged in a spectrum of complimentary research. Her particular interests include: identifying genetic risk factors for the side-effects of common cardiovascular treatments; investigating causality in relation to factors such as adiposity and dementia that are responsible for major burdens of disease, using the large UK and China Kadoorie biobanks.
Adiposity and risk of ischaemic and haemorrhagic stroke in Chinese men and women: a prospective study of 0.5 million adults
Chen Z. et al, (2018), The Lancet Global Health
Adiposity and risk of ischaemic and haemorrhagic stroke in 0·5 million Chinese men and women: a prospective cohort study.
Chen Z. et al, (2018), Lancet Glob Health, 6, e630 - e640
Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults.
Lu L. et al, (2018), PLoS Med, 15
Impact of CKD on Household Income.
Morton RL. et al, (2018), Kidney Int Rep, 3, 610 - 618
Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke.
Holmes MV. et al, (2018), J Am Coll Cardiol, 71, 620 - 632